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Abstract The plant toxin ricin has to be transported to the
Golgi apparatus after endocytosis to exert its toxic effect. In this
study we show that transport of apically endocytosed ricin to the
Golgi apparatus is stimulated by 8-Br-cAMP in polarized
MDCK cells. This stimulation is counteracted by the PKA
inhibitor H-89. In contrast, there is no increase in the transport
to the Golgi apparatus of ricin internalized from the basolateral
membrane. These results suggest that protein kinase A
selectively regulates endosome to Golgi transport in these cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Polarized MDCK cells contain two compositionally and
functionally di¡erent plasma membrane domains, the apical
and the basolateral. Several transport pathways such as endo-
cytosis, transcytosis and transport along the biosynthetic
pathway are di¡erentially regulated in polarized cells depend-
ing on the plasma membrane domain that is involved. In the
biosynthetic pathway, heterotrimeric Gs proteins [1], protein
kinase A (PKA) [2^4] and protein kinase C (PKC) [4] regulate
constitutive transport from the Golgi apparatus to the apical
plasma membrane, whereas the small GTPase Rab8 [5], het-
erotrimeric Gi proteins [1] and myosin II [6] are involved in
vesicular tra⁄c between the Golgi apparatus and the baso-
lateral plasma membrane. Also transport from endosomes to
the Golgi apparatus is under regulation, but much less is
known about this transport step and whether it is di¡eren-
tially a¡ected depending on the pole involved in endocytosis
of the ligand. By using the plant toxin ricin we have earlier
found that brefeldin A [7], monensin [8] and calmodulin an-
tagonists [9] regulate endosome to Golgi transport in MDCK
cells. We here present evidence that 8-Br-cAMP, an activator
of PKA known to a¡ect both endocytosis [10], transcytosis
[2,10] and transport from the Golgi apparatus to the apical
plasma membrane [2] in MDCK cells, also stimulates trans-
port of ricin to the Golgi apparatus after apical endocytosis.
In contrast, there is no signi¢cant e¡ect on the transport of
ricin to the Golgi apparatus after basolateral endocytosis.
These results provide evidence for an additional role of
PKA in vesicular transport, and demonstrate that endosome
to Golgi transport is di¡erentially regulated by cAMP de-
pending on the pole from where endocytosis occurs.
2. Materials and methods
2.1. Materials
8-Br-cAMP, p-nitrophenyl-N-acetyl-L-D-glucosaminide, horseradish
peroxidase (HRP) type VI, o-dianisidine, HEPES, lactose, and bovine
serum albumin (BSA) were obtained from Sigma Chemical Co., St.
Louis, MO, USA. Imidazole was obtained from Serva Biochemicals,
Heidelberg, Germany. Sucrose was obtained from Merck, Darmstadt,
Germany. H-89 was obtained from Seikagaku Corp., Tokyo, Japan.
[3H]Leucine, Na125I and UDP-D-[6-3H]galactose ammonium were ob-
tained from the Radiochemical Centre, Amersham, UK. Nycodenz
was obtained from Nycomed, Oslo, Norway. Ricin was labelled by
the iodogen method [11].
2.2. Cell culture
MDCK cells (strain I) [12] were grown either in 175 cm2 £asks and
passaged every 3^4 days or on polycarbonate ¢lters (Costar Trans-
well, pore size: 0.4 Wm, diameter: 24.5 mm) at a density of 106 cells
per ¢lter and used 4^5 days later. The cells were maintained in
DMEM (Flow Laboratories, Irvine, UK) supplemented with 5% fetal
calf serum, 100 units/ml penicillin, 100 Wg/ml streptomycin and 2 mM
L-glutamine. The transepithelial resistance of the monolayer was
measured with a Millicell-ERS equipment (Millipore Corporation,
Bedford, MA, USA) at the beginning of the experiments. Filters
with a transepithelial resistance higher than 1000 6 cm2 were used.
The experiments were carried out in HEPES (20 mM)-bu¡ered MEM
with 0.2% BSA.
2.3. Subcellular fractionation
Subcellular fractionation after incubation with 125I-ricin and HRP
was carried out essentially as described by Sandvig et al. [13]. Filters
with polarized cells were cut out of their plastic holders and, in those
cases where 125I-ricin was present, washed with constant shaking four
times for 15 min with a cold PBS solution containing 0.1 M lactose
and 0.2% BSA to remove surface-bound toxin [14]. Homogenization
bu¡er (H-bu¡er) (0.3 M sucrose, 3 mM imidazole, pH 7.4) (1 ml) was
then added to each ¢lter and the cells were scraped o¡ with a rubber
policeman. This procedure was repeated and ¢nally H-bu¡er (1 ml)
was added to wash the ¢lters. For each gradient cells from two or
three ¢lters were collected and centrifuged for 10 min at 100Ug at
4‡C. The supernatant was removed and the pellet was resuspended in
H-bu¡er (1 ml) and homogenized by passing it 3^4 times up and
down through a 1 ml tip, followed by 3^4 times through a 1-ml
syringe with a 22GU1.5Q needle. The homogenate was centrifuged
for 10 min at 2500 rpm in an Eppendorf centrifuge (model 5415).
Postnuclear supernatant (0.660 ml) was mixed with a 2 M sucrose
solution (0.880 ml) and then added to a SW 40 tube containing 4 ml
of a 1.15 M sucrose, 15 mM CsCl solution (light solution) and 1.5 ml
of a 1.15 M sucrose, 15 mM CsCl, 15% Nycodenz (w/v) solution
(heavy solution) mixed in a Biocomp Gradient Master, Nycomed,
Oslo, Norway (angle 74, speed 16, time 2P 45P). Then, 3 ml of a
0.9 M sucrose solution was added and the tube was ¢lled with 1.5^
2 ml H-bu¡er. The gradients were centrifuged for 4.5 h at 33 000 rpm
at 4‡C and fractionated into 24^26 portions.
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2.4. Subcellular fractionation analysis
The amount of 125I-ricin in the Golgi apparatus was calculated
from the radioactivity found in the fractions that were shown to
contain this organelle by measuring UDP-galactose/glycoprotein gal-
actosyl transferase activity according to Brandli et al. [15]. The activ-
ity of the lysosomal enzyme L-N-acetyl-glucosaminidase in each frac-
tion was determined as described by Beaufay et al. [16]. HRP activity
was determined according to Steinman et al. [17].
3. Results
The goal of this study was to investigate whether transport
of ricin from endosomes to the Golgi apparatus is regulated
by cAMP in polarized MDCK cells. Ricin does not dissociate
at low endosomal pH, and it has previously been shown to be
transported to the Golgi apparatus in a number of cell lines
[18], including polarized MDCK cells [19]. In these cells, ricin
is endocytosed from both the apical and the basolateral plas-
ma membrane after binding to glycoproteins and glycolipids
containing terminal galactose [19]. In the present study polar-
ized MDCK cells were incubated with 125I-ricin in the absence
or in the presence of 8-Br-cAMP, and Golgi-enriched frac-
tions were isolated by subcellular fractionation. As previously
described [13,20], the method used here allows us to distin-
guish three di¡erent zones: zone I (top of the gradient) con-
taining Golgi-enriched fractions, zone II where the sample
was loaded, and zone III (bottom of the gradient) containing
fractions enriched in lysosomes and endosomes. This is dem-
onstrated in Fig. 1, where the activity pro¢les of the Golgi
marker UDP-galactosyl transferase (open symbols) and the
lysosomal marker L-N-acetyl-glucosaminidase (closed sym-
bols) in control cells and in cells treated with the membrane
permeant cAMP analogue, 8-Br-cAMP (1 mM), for 90 min
are shown. A considerable percentage of the total UDP-gal-
actosyl transferase activity and an insigni¢cant percentage of
the total L-N-acetyl-glucosaminidase activity of the gradient
are found in zone I, indicating that zone I contains Golgi-
enriched fractions which are not contaminated by lysosomal
content, which is mainly found in zone III. A slightly lower
percentage of the total activity of the Golgi enzyme seems to
be present in zone I in cells treated with 8-Br-cAMP than in
control cells. This may be due to some loss of intact Golgi
stacks during homogenization. In any case, the pro¢les of the
two enzymes investigated do not seem to be altered by 8-Br-
cAMP. Also, we have previously found that the Golgi-en-
riched fractions are essentially free of early and late endo-
somes [13]. When MDCK cells were incubated with HRP
for 10 min to label early endosomes or for 10 min followed
by a 40 min chase to label late endosomes/lysosomes, only
0.4% of the total HRP activity was associated with zone I
(Golgi-enriched fractions) [13]. In this study we have also
used HRP to measure a possible contamination of the Gol-
gi-enriched fractions with early and late endosomes in the
absence and in the presence of 8-Br-cAMP. To label early
and late endosomes MDCK cells were incubated with HRP
(2 mg/ml) for 90 min. The cells were then washed, homogen-
ized and fractionated. Measurements of the HRP activity in
the di¡erent fractions of the gradient con¢rmed that the con-
tamination of the Golgi-enriched fractions with endosomes
was very low. Furthermore, the HRP activity in these frac-
tions was not increased by 8-Br-cAMP treatment (data not
shown).
To investigate the e¡ect of 8-Br-cAMP on transport of ricin
to the Golgi apparatus, ¢lter-grown MDCK cells were prein-
cubated with or without 8-Br-cAMP (1 mM) for 30 min be-
fore 125I-ricin (V200 ng/ml, 30 000^40 000 cpm/ng) was
added. One hour later the cells were washed with PBS con-
taining lactose (0.1 M) and BSA (0.2%) to remove surface-
bound toxin and then homogenized and fractionated as de-
scribed in Section 2. The results obtained in several experi-
ments are summarized in Table 1, and the data show that 8-
Br-cAMP increases the transport of ricin to the Golgi appa-
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Fig. 1. UDP-galactosyltransferase and L-N-acetyl-glucosaminidase
activity pro¢les in subcellular fractions of MDCK cells. Polarized
MDCK cells were incubated for 90 min without or with 8-Br-cAMP
(1 mM) and then homogenized and fractionated. The activities of
UDP-galactosyltransferase (a) and L-N-acetyl glucosaminidase (b)
were measured in each fraction as described in Section 2. Zone I:
fractions enriched in the Golgi apparatus. Zone II, load zone. Zone
III, fractions enriched in endosomes and lysosomes.
Table 1
E¡ect of 8-Br-cAMP on transport of endocytosed ricin to the Golgi
apparatus
Toxin administration Ricin in Golgi fractionsa
(% of control, no additions)
Apical 38-Br-cAMP 100
+8-Br-cAMP 143.8 þ 15.8 (n = 6)
Basolateral 38-Br-cAMP 100
+8-Br-cAMP 87.1 þ 6.4 (n = 8)
Filter-grown MDCK cells were incubated with or without 8-Br-cAMP
(1 mM) for 30 min before 125I-ricin (V200 ng/ml, 30 000^40 000 ng/
ml) was added to the apical or the basolateral plasma membrane. The
incubation was continued for 1 h and then surface-bound toxin was
removed. Homogenization and subcellular fractionation were per-
formed as described in Section 2. The results are given as the mean
of 6^8 experiments þ S.D.
aCalculated in percent of the amount of ricin endocytosed.
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ratus after apical internalization to 140%. It should be noted
that the amount of ricin in the Golgi apparatus is always
calculated in percent of the total amount of ricin endocytosed
to correct for a change in the rate of endocytosis. The stim-
ulation is restricted to toxin entry from the apical side. After
basolateral addition the transport of ricin to the Golgi appa-
ratus seems to be slightly inhibited. Fig. 2A,B shows the per-
centage of the total radioactivity found in each fraction of the
gradient after apical (A) or basolateral (B) addition of ricin in
the absence (open symbols) and in the presence (closed sym-
bols) of 8-Br-cAMP of a representative experiment. The Gol-
gi-enriched fractions of these gradients are also shown in Fig.
3. As described above the Golgi-enriched fractions were not
signi¢cantly contaminated with early or late endosomes. Also,
to demonstrate that there was no lysosomal contamination in
zone I, the pro¢les of the lysosomal enzyme L-N-acetyl-gluco-
saminidase activity are represented in Fig. 2C,D (same frac-
tions as in Fig. 2A,B respectively). Interestingly, the amount
of 125I-ricin (% of total radioactivity) found in the Golgi ap-
paratus after apical endocytosis (Figs. 2A and 3A) is increased
by 8-Br-cAMP. In contrast, 8-Br-cAMP does not increase the
transport of ricin to the Golgi apparatus when the toxin is
internalized from the basolateral side (Figs. 2B and 3B). It has
previously been shown that ricin does not reach the Golgi
apparatus at 17‡C [21] and, as shown in Fig. 3, both after
apical (A) and basolateral (B) uptake of 125I-ricin in the ab-
sence (open symbols) or in the presence (closed symbols) of 8-
Br-cAMP, the amount of labelled toxin found in the Golgi-
enriched fractions (zone I) was signi¢cantly lower at 17‡C
than at 37‡C. Importantly, at 17‡C there was no di¡erence
in the amount of ricin found in the Golgi-enriched fractions
between cells incubated with or without 8-Br-cAMP. These
results are in agreement with the idea that the radioactivity
found in zone I at 37‡C is mainly due to 125I-ricin that has
reached the Golgi apparatus and not due to endosomal or
lysosomal contamination.
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Fig. 2. 125I-Ricin (A,B) and L-N-acetyl-glucosaminidase (C,D) activity pro¢les from cells incubated without or with 8-Br-cAMP. Filter-grown
cells were incubated without (a) or with (b) 8-Br-cAMP (1 mM) for 30 min at 37‡C. Then 125I-ricin (V200 ng/ml, 30 000^40 000 cpm/ng) was
added either to the apical (A) or to the basolateral (B) side. After 1 h surface-bound ricin was removed with 0.1 M lactose and subcellular
fractionation was performed as described in Section 2. Pro¢les A and B: 125I-ricin radioactivity after apical and basolateral internalization re-
spectively. Pro¢les C and D: L-N-acetyl-glucosaminidase activity corresponding to the fractions in A and B. Zone I, fractions enriched in the
Golgi apparatus. Zone II, load zone. Zone III, fractions enriched in endosomes and lysosomes.
Fig. 3. E¡ect of 8-Br-cAMP and temperature on the amount of ri-
cin found in Golgi-enriched fractions after apical (A) or basolateral
(B) internalization. No additions 37‡C, (a) ; 8-Br-cAMP 37‡C (b) ;
no additions 17‡C (O) ; 8-Br-cAMP 17‡C (R). Only zone I is
shown.
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Finally, to investigate whether PKA is involved in the 8-Br-
cAMP-induced stimulation of apical endocytosis, ¢lter-grown
cells were incubated with the PKA inhibitor H-89 [22] (20
WM) for 30 min before 8-Br-cAMP and 125I-ricin were added.
The experiment was continued as described above. As shown
in Fig. 4, H-89 signi¢cantly decreased the stimulation caused
by 8-Br-cAMP, suggesting that PKA is involved in the regu-
lation of endosome to Golgi transport.
4. Discussion
In the present study the e¡ect of the PKA activator 8-Br-
cAMP on the transport of ricin internalized from both the
apical and the basolateral plasma membrane of MDCK cells
to the Golgi apparatus has been investigated. Subcellular frac-
tionation studies show that 8-Br-cAMP selectively stimulates
transport of ricin from the endosomes to the Golgi apparatus
after apical endocytosis. The stimulation is counteracted by a
PKA inhibitor, H-89, indicating that the e¡ect of 8-Br-cAMP
is mediated via this enzyme. cAMP has previously been shown
to stimulate apical endocytosis [10], transcytosis in both direc-
tions [2,10], and transport from the trans-Golgi network to
the apical plasma membrane [2,3] in MDCK cells presumably
via PKA. In fact, cAMP regulates Golgi to apical plasma
membrane transport to the same extent [1,4] (approximately
to 140% of the control) as endosome to Golgi transport.
Thus, although it has previously been shown that only a small
fraction of ricin that is transported to the Golgi apparatus is
exported back to the medium [23], the stimulatory e¡ect of 8-
Br-cAMP on ricin transport to the Golgi apparatus cannot be
explained by a reduced export of the toxin.
Multiple forms of both regulatory and catalytic subunits of
PKA are known. The discovery of a large family of proteins
denominated A-kinase anchoring proteins (AKAPs) (for re-
view see [24,25]) that serve to anchor PKA to di¡erent cellular
targets has been a step forward to understand the presence of
PKA at di¡erent locations and the localized action of cAMP.
AKAPs have been found in association with the endoplasmic
reticulum, Golgi apparatus, plasma membrane, centrosomes,
microtubules, actin cytoskeleton, nuclear matrix, mitochon-
dria, and peroxisomes [25]. So far, AKAPs have not been
identi¢ed in endosomes, but the possibility exists that one of
these proteins attaches PKA to endosomes where the enzyme
may phosphorylate a substrate involved in the budding of
vesicles destined to the Golgi apparatus. Alternatively, PKA
could modify the vesicle itself or the Golgi apparatus, increas-
ing the probability or the rate of fusion with the Golgi appa-
ratus.
In MDCK cells endosomes originating from the apical and
the basolateral pole are two di¡erent populations that do not
fuse with each other. Their contents seem to meet in late
endosomes [26]. It is not established whether ricin is trans-
ported to the Golgi apparatus only from late endosomes or
whether it can be transported to the Golgi apparatus also
from an earlier compartment. The fact that the transport of
ricin to the Golgi apparatus after apical and basolateral en-
docytosis is independently regulated is in agreement with the
latter hypothesis. In fact, it is not only 8-Br-cAMP that causes
a di¡erential regulation of ricin transport to the Golgi appa-
ratus from the two poles of polarized MDCK cells [7^9].
Furthermore, increased transport to the Golgi apparatus is
not necessarily associated with an increased or changed endo-
cytosis. We have previously found that monensin increases
apical endocytosis without changing transport of apically in-
ternalized ricin to the Golgi apparatus. Also, monensin in-
creases the transport of basolaterally internalized ricin to
the Golgi apparatus without a¡ecting toxin endocytosis at
the basolateral pole [8]. On the other hand, brefeldin A [7]
and calmodulin antagonists [9] decrease the transport of ba-
solaterally internalized ricin to the Golgi apparatus without
changing basolateral endocytosis of the toxin. The data dis-
cussed above furthermore illustrate that an apparent change
in Golgi transport is not an artefact due to a changed amount
of ricin in endosomes/lysosomes. We cannot exclude that 8-
Br-cAMP stimulates a step, for instance between endosomes,
preceding transport to the Golgi apparatus since we found an
increased net £ux from endosomes to this organelle. However,
endosome fusion has been shown to be inhibited by cAMP in
a cell-free assay prepared from BHK-21 cells [27]. Further-
more, transcytosis of ricin is stimulated by 8-Br-cAMP in
MDCK cells in both directions [2,10], and not only from
the apical side. In fact, the stimulatory e¡ect of the cAMP
analog is larger for basolateral to apical transcytosis than in
the other direction. Thus, there is no correlation between the
e¡ect of 8-Br-cAMP on transcytosis and Golgi transport.
The localization of di¡erent coats (clathrin and COP-I) on
endosomes has recently been published [28,29], and one might
imagine that these coats could be involved in transport from
endosomes to the Golgi apparatus, possibly via another com-
partment. It has been shown that brefeldin A inhibits the
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Fig. 4. Ability of H-89 to counteract the 8-Br-cAMP-induced stimu-
lation of the transport of ricin to the Golgi apparatus. Filter-grown
MDCK cells were incubated in HEPES medium with 0.2% BSA
(lane 1), in the same medium with 8-Br-cAMP (1 mM) for 30 min
(lane 2), or with 8-Br-cAMP (1 mM) after a 30 min preincubation
with H-89 (20 WM) (lane 3) before 125I-ricin was added. After 1 h
at 37‡C surface-bound ricin was removed and the experiment was
continued as described in Section 2. The error bars show deviation
between duplicates.
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binding of COP-I to endosomes from CHO cells in vitro [30],
the formation of clathrin-coated buds on endosomes in A431
cells [29], and possibly also binding of coats to endosomes in
MDCK cells is inhibited since brefeldin A a¡ects endosomal
morphology in these cells [31]. However, in MDCK cells the
Golgi is resistant to brefeldin A, and this drug stimulates
transport of ricin to the Golgi apparatus after apical endocy-
tosis [7], thus suggesting that the endosomal coats may not be
required for the transport of ricin from endosomes to the
Golgi. Also, recruitment of COP coats to endosomes has
been reported to require low pH [28], whereas ricin transport
to the Golgi apparatus in MDCK cells is not dependent on
low endosomal pH [8]. cAMP has so far been shown to reg-
ulate vesicular transport that does not originate in clathrin-
coated pits, such as clathrin-independent apical endocytosis
and constitutive transport from the Golgi apparatus to the
apical pole of polarized MDCK cells [2,3,10]. In analogy,
cAMP might regulate a clathrin-independent step between
endosomes and the Golgi apparatus. Clearly, further work
is required to understand the di¡erent pathways involved in
ricin transport.
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